Agape ATP Corp (ATPC) received a delisting determination from Nasdaq on February 5 2026 after its closing bid price fell to $0.10 or less for ten consecutive trading days, violating the exchange’s Low‑Priced Stocks rule and the $1.00 minimum bid price requirement.
The notice also cited ATPC’s market capitalization of $4.20 million, below Nasdaq’s $5 million threshold for listed companies, and identified deficiencies in the company’s public disclosure and corporate governance practices, including incomplete reporting of executive compensation and board composition.
In response, ATPC has scheduled a 1‑for‑50 reverse stock split effective February 10 2026 to lift its share price above the $1.00 minimum and has filed a request to the Nasdaq Hearings Panel to appeal the delisting determination, a process that can temporarily suspend the removal of its shares.
ATPC operates in the health and wellness sector, generating the majority of its revenue from dietary supplements and wellness programs. Recent financials show declining earnings, with a trailing‑12‑month EPS of –$0.10 and a market cap that has fallen from $6.5 million in 2024 to $4.20 million, underscoring the company’s liquidity and profitability challenges.
The delisting risk signals a significant shift in ATPC’s capital‑raising prospects. Without Nasdaq listing, the company would need to seek alternative venues such as the OTC market or a private placement, which could limit access to capital and increase borrowing costs, potentially accelerating its financial deterioration.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.